لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

المؤلفون: Mascardi MF; Instituto de Medicina Traslacional e Ingeniería Biomédica (IMTIB) - CONICET - Instituto Universitario del Hospital Italiano (IUHI) - Hospital Italiano de Buenos Aires (HIBA), Buenos Aires, Argentina.; Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Buenos Aires, Argentina., Mazzini FN; Instituto de Medicina Traslacional e Ingeniería Biomédica (IMTIB) - CONICET - Instituto Universitario del Hospital Italiano (IUHI) - Hospital Italiano de Buenos Aires (HIBA), Buenos Aires, Argentina., Suárez B; Instituto de Medicina Traslacional e Ingeniería Biomédica (IMTIB) - CONICET - Instituto Universitario del Hospital Italiano (IUHI) - Hospital Italiano de Buenos Aires (HIBA), Buenos Aires, Argentina.; Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Buenos Aires, Argentina., Ruda VM; Biotherapeutic and Analytical Technologies, Novartis Institutes for Biomedical Research (NIBR), Cambridge, Massachusetts, USA., Marciano S; Liver Unit of Hospital Italiano de Buenos Aires, Buenos Aires, Argentina., Casciato P; Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Buenos Aires, Argentina.; Liver Unit of Hospital Italiano de Buenos Aires, Buenos Aires, Argentina., Narvaez A; Liver Unit of Hospital Italiano de Buenos Aires, Buenos Aires, Argentina., Haddad L; Liver Unit of Hospital Italiano de Buenos Aires, Buenos Aires, Argentina., Anders M; Liver Unit of Hospital Alemán, Buenos Aires, Argentina., Orozco F; Liver Unit of Hospital Alemán, Buenos Aires, Argentina., Tamaroff AJ; Nutrition Department of Hospital Italiano de Buenos Aires, Buenos Aires, Argentina., Cook F; Analytical Sciences & Imaging Department, NIBR, Cambridge, Massachusetts, USA., Gounarides J; Analytical Sciences & Imaging Department, NIBR, Cambridge, Massachusetts, USA., Gutt S; Nutrition Department of Hospital Italiano de Buenos Aires, Buenos Aires, Argentina., Gadano A; Liver Unit of Hospital Italiano de Buenos Aires, Buenos Aires, Argentina., García CM; Chemical Biology & Therapeutics Department, NIBR, Cambridge, Massachusetts, USA., Marro ML; Cardiovascular and Metabolic Disease Area, NIBR, Cambridge, Massachusetts, USA., Penas Steinhardt A; Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Buenos Aires, Argentina.; Departamento de Ciencias Básicas, Laboratorio de Genómica Computacional, Universidad Nacional de Luján, Lujan, Buenos Aires, Argentina., Trinks J; Instituto de Medicina Traslacional e Ingeniería Biomédica (IMTIB) - CONICET - Instituto Universitario del Hospital Italiano (IUHI) - Hospital Italiano de Buenos Aires (HIBA), Buenos Aires, Argentina.; Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Buenos Aires, Argentina.

المصدر: Proteomics [Proteomics] 2023 Sep; Vol. 23 (18), pp. e2200414. Date of Electronic Publication: 2023 Jul 31.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Wiley-VCH Country of Publication: Germany NLM ID: 101092707 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1615-9861 (Electronic) Linking ISSN: 16159853 NLM ISO Abbreviation: Proteomics Subsets: MEDLINE

مواضيع طبية MeSH: Gastrointestinal Microbiome*/genetics , Acyltransferases*/genetics , Phospholipases A2, Calcium-Independent*/genetics , Non-alcoholic Fatty Liver Disease*/genetics , Non-alcoholic Fatty Liver Disease*/microbiology, Humans ; Genotype ; Metabolome ; Transcriptome/genetics

المؤلفون: Mustoe AM; Department of Chemistry, University of North Carolina, Chapel Hill, NC, USA. Electronic address: amustoe@unc.edu., Busan S; Department of Chemistry, University of North Carolina, Chapel Hill, NC, USA., Rice GM; Department of Chemistry, University of North Carolina, Chapel Hill, NC, USA; Novartis Institutes for Biomedical Research, Inc., Cambridge, MA, USA., Hajdin CE; Novartis Institutes for Biomedical Research, Inc., Cambridge, MA, USA., Peterson BK; Novartis Institutes for Biomedical Research, Inc., Cambridge, MA, USA., Ruda VM; Novartis Institutes for Biomedical Research, Inc., Cambridge, MA, USA., Kubica N; Novartis Institutes for Biomedical Research, Inc., Cambridge, MA, USA., Nutiu R; Novartis Institutes for Biomedical Research, Inc., Cambridge, MA, USA., Baryza JL; Novartis Institutes for Biomedical Research, Inc., Cambridge, MA, USA., Weeks KM; Department of Chemistry, University of North Carolina, Chapel Hill, NC, USA. Electronic address: weeks@unc.edu.

المصدر: Cell [Cell] 2018 Mar 22; Vol. 173 (1), pp. 181-195.e18. Date of Electronic Publication: 2018 Mar 15.

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.

بيانات الدورية: Publisher: Cell Press Country of Publication: United States NLM ID: 0413066 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-4172 (Electronic) Linking ISSN: 00928674 NLM ISO Abbreviation: Cell Subsets: MEDLINE

مواضيع طبية MeSH: Nucleic Acid Amplification Techniques/*methods , RNA, Messenger/*metabolism, Algorithms ; Binding Sites ; Cell-Free System ; DNA Primers/metabolism ; Electrophoretic Mobility Shift Assay ; Entropy ; Escherichia coli/genetics ; Escherichia coli/metabolism ; Escherichia coli Proteins/chemistry ; Escherichia coli Proteins/genetics ; Escherichia coli Proteins/metabolism ; Models, Molecular ; Nucleic Acid Conformation ; Protein Biosynthesis ; RNA Folding ; RNA, Messenger/chemistry ; Recombinant Proteins/biosynthesis ; Recombinant Proteins/chemistry ; Recombinant Proteins/isolation & purification ; Ribosomes/chemistry ; Ribosomes/metabolism ; Untranslated Regions

المؤلفون: Tam HH; Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139., Melo MB; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139; Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, & Harvard, Cambridge, MA 02139., Kang M; Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139; Institute for Medical Engineering & Science, Massachusetts Institute of Technology, Cambridge, MA 02139., Pelet JM; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139., Ruda VM; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139., Foley MH; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139., Hu JK; Division of Vaccine Discovery, La Jolla Institute for Allergy & Immunology, La Jolla, CA 92037., Kumari S; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139; Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, & Harvard, Cambridge, MA 02139., Crampton J; Division of Vaccine Discovery, La Jolla Institute for Allergy & Immunology, La Jolla, CA 92037., Baldeon AD; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139., Sanders RW; Department of Microbiology and Immunology, Weill Medical College of Cornell University, New York, NY 10021; Department of Medical Microbiology, Academic Medical Center, University of Amsterdam, 1105 AZ Amsterdam-Zuidoost, The Netherlands., Moore JP; Department of Microbiology and Immunology, Weill Medical College of Cornell University, New York, NY 10021., Crotty S; Division of Vaccine Discovery, La Jolla Institute for Allergy & Immunology, La Jolla, CA 92037; Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery, La Jolla, CA 92037; Department of Medicine, University of California, San Diego School of Medicine, La Jolla, CA 92037., Langer R; Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139; Institute for Medical Engineering & Science, Massachusetts Institute of Technology, Cambridge, MA 02139., Anderson DG; Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139; Institute for Medical Engineering & Science, Massachusetts Institute of Technology, Cambridge, MA 02139; djirvine@mit.edu dgander@mit.edu arupc@mit.edu., Chakraborty AK; Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139; Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, & Harvard, Cambridge, MA 02139; Institute for Medical Engineering & Science, Massachusetts Institute of Technology, Cambridge, MA 02139; Department of Physics, Massachusetts Institute of Technology, Cambridge, MA 02139; Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139; Department of Chemistry, Massachusetts Institute of Technology, Cambridge, MA 02139; djirvine@mit.edu dgander@mit.edu arupc@mit.edu., Irvine DJ; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139; Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, & Harvard, Cambridge, MA 02139; Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery, La Jolla, CA 92037; Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139; Howard Hughes Medical Institute, Chevy Chase, MD 20815 djirvine@mit.edu dgander@mit.edu arupc@mit.edu.

المصدر: Proceedings of the National Academy of Sciences of the United States of America [Proc Natl Acad Sci U S A] 2016 Oct 25; Vol. 113 (43), pp. E6639-E6648. Date of Electronic Publication: 2016 Oct 04.

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: National Academy of Sciences Country of Publication: United States NLM ID: 7505876 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1091-6490 (Electronic) Linking ISSN: 00278424 NLM ISO Abbreviation: Proc Natl Acad Sci U S A Subsets: MEDLINE

مواضيع طبية MeSH: AIDS Vaccines/*administration & dosage , Antibodies, Viral/*biosynthesis , B-Lymphocytes/*drug effects , Germinal Center/*drug effects , HIV Envelope Protein gp120/*administration & dosage , Vaccination/*methods, Adjuvants, Immunologic/administration & dosage ; Animals ; Antibody Affinity ; B-Lymphocytes/cytology ; B-Lymphocytes/immunology ; CHO Cells ; Cricetulus ; Drug Administration Schedule ; Female ; Germinal Center/cytology ; Germinal Center/immunology ; HEK293 Cells ; HIV Envelope Protein gp120/biosynthesis ; Humans ; Immunogenicity, Vaccine ; Infusion Pumps, Implantable ; Lipid A/administration & dosage ; Lipid A/analogs & derivatives ; Mice ; Mice, Inbred C57BL ; Osmotic Pressure ; Recombinant Fusion Proteins/administration & dosage ; Recombinant Fusion Proteins/biosynthesis ; Vaccination/instrumentation

المؤلفون: Dutta P; Center for Systems Biology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114 mnahrendorf@mgh.harvard.edu dutta.partha@mgh.harvard.edu., Hoyer FF; Center for Systems Biology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114., Grigoryeva LS; Center for Systems Biology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114., Sager HB; Center for Systems Biology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114., Leuschner F; Department of Cardiology, Medical University Hospital Heidelberg, D-69120 Heidelberg, Germany DZHK (German Centre for Cardiovascular Research), partner site Heidelberg/Mannheim, D-69120 Heidelberg, Germany., Courties G; Center for Systems Biology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114., Borodovsky A; Alnylam Pharmaceuticals, Cambridge, MA 02142., Novobrantseva T; Alnylam Pharmaceuticals, Cambridge, MA 02142., Ruda VM; Alnylam Pharmaceuticals, Cambridge, MA 02142., Fitzgerald K; Alnylam Pharmaceuticals, Cambridge, MA 02142., Iwamoto Y; Center for Systems Biology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114., Wojtkiewicz G; Center for Systems Biology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114., Sun Y; Center for Systems Biology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114., Da Silva N; Center for Systems Biology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114., Libby P; Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Boston, MA 02115., Anderson DG; David H. Koch Institute for Integrative Cancer Research, Department of Chemical Engineering, and Institute for Medical Engineering and Science, Massachusetts Institute of Technology, Cambridge, MA 02142 David H. Koch Institute for Integrative Cancer Research, Department of Chemical Engineering, and Institute for Medical Engineering and Science, Massachusetts Institute of Technology, Cambridge, MA 02142 David H. Koch Institute for Integrative Cancer Research, Department of Chemical Engineering, and Institute for Medical Engineering and Science, Massachusetts Institute of Technology, Cambridge, MA 02142 Division of Health Science Technology, Harvard University and Massachusetts Institute of Technology, Cambridge, MA 02139., Swirski FK; Center for Systems Biology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114., Weissleder R; Center for Systems Biology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114 Department of Systems Biology, Harvard Medical School, Boston, MA 02115., Nahrendorf M; Center for Systems Biology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114 mnahrendorf@mgh.harvard.edu dutta.partha@mgh.harvard.edu.

المصدر: The Journal of experimental medicine [J Exp Med] 2015 Apr 06; Vol. 212 (4), pp. 497-512. Date of Electronic Publication: 2015 Mar 23.

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Rockefeller University Press Country of Publication: United States NLM ID: 2985109R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1540-9538 (Electronic) Linking ISSN: 00221007 NLM ISO Abbreviation: J Exp Med Subsets: MEDLINE

مواضيع طبية MeSH: Hematopoiesis, Extramedullary/*immunology , Hematopoietic Stem Cells/*immunology , Macrophages/*immunology , Myelopoiesis/*immunology , Spleen/*immunology , Vascular Cell Adhesion Molecule-1/*immunology, Animals ; Apolipoproteins E/genetics ; Apolipoproteins E/immunology ; Atherosclerosis/genetics ; Atherosclerosis/immunology ; Atherosclerosis/pathology ; Gene Expression Regulation/genetics ; Gene Expression Regulation/immunology ; Hematopoiesis, Extramedullary/genetics ; Hematopoietic Stem Cells/pathology ; Macrophages/pathology ; Mice ; Mice, Knockout ; Myelopoiesis/genetics ; Myocardial Infarction/genetics ; Myocardial Infarction/immunology ; Myocardial Infarction/pathology ; Nanoparticles ; Plaque, Atherosclerotic/genetics ; Plaque, Atherosclerotic/immunology ; Plaque, Atherosclerotic/pathology ; RNA Interference ; Receptor, Macrophage Colony-Stimulating Factor/genetics ; Receptor, Macrophage Colony-Stimulating Factor/immunology ; Sialic Acid Binding Ig-like Lectin 1/genetics ; Sialic Acid Binding Ig-like Lectin 1/immunology ; Spleen/pathology ; Vascular Cell Adhesion Molecule-1/genetics

المؤلفون: Dahlman JE; Harvard-MIT Division of Health Sciences and Technology, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA.; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA.; Institute for Medical Engineering and Science, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA., Barnes C; Alnylam Pharmaceuticals, Cambridge, Massachusetts 02139, USA., Khan O; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA.; Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA., Thiriot A; Department of Microbiology and Immunology, Harvard Medical School, Boston 02115, USA., Jhunjunwala S; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA., Shaw TE; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA., Xing Y; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA., Sager HB; Center for Systems Biology, Massachusetts General Hospital and Harvard Medical School, Boston 02114, USA., Sahay G; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA., Speciner L; Alnylam Pharmaceuticals, Cambridge, Massachusetts 02139, USA., Bader A; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA., Bogorad RL; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA., Yin H; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA., Racie T; Alnylam Pharmaceuticals, Cambridge, Massachusetts 02139, USA., Dong Y; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA., Jiang S; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA., Seedorf D; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA., Dave A; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA., Sandu KS; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA., Webber MJ; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA., Novobrantseva T; Alnylam Pharmaceuticals, Cambridge, Massachusetts 02139, USA., Ruda VM; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA., Lytton-Jean AKR; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA., Levins CG; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA., Kalish B; Vascular Biology Program, Children's Hospital Boston, and Division of Pediatric Oncology, Dana Farber Cancer Institute, Harvard Medical School, Boston 02115, USA., Mudge DK; Vascular Biology Program, Children's Hospital Boston, and Division of Pediatric Oncology, Dana Farber Cancer Institute, Harvard Medical School, Boston 02115, USA., Perez M; Program in Translational Lung Research, Division of Pulmonary Sciences and Critical Care Program, Department of Medicine, University of Colorado School of Medicine, Aurora, USA., Abezgauz L; Deparment of Biotechnology and Food Engineering, and The Russell Berrie Nanotechnology Institute, Technion Israel Institute of Technology, Haifa 3200, Israel., Dutta P; Center for Systems Biology, Massachusetts General Hospital and Harvard Medical School, Boston 02114, USA., Smith L; Program in Translational Lung Research, Division of Pulmonary Sciences and Critical Care Program, Department of Medicine, University of Colorado School of Medicine, Aurora, USA., Charisse K; Alnylam Pharmaceuticals, Cambridge, Massachusetts 02139, USA., Kieran MW; Department of Microbiology and Immunology, Harvard Medical School, Boston 02115, USA., Fitzgerald K; Alnylam Pharmaceuticals, Cambridge, Massachusetts 02139, USA., Nahrendorf M; Center for Systems Biology, Massachusetts General Hospital and Harvard Medical School, Boston 02114, USA., Danino D; Deparment of Biotechnology and Food Engineering, and The Russell Berrie Nanotechnology Institute, Technion Israel Institute of Technology, Haifa 3200, Israel., Tuder RM; Program in Translational Lung Research, Division of Pulmonary Sciences and Critical Care Program, Department of Medicine, University of Colorado School of Medicine, Aurora, USA., von Andrian UH; Department of Microbiology and Immunology, Harvard Medical School, Boston 02115, USA., Akinc A; Alnylam Pharmaceuticals, Cambridge, Massachusetts 02139, USA., Schroeder A; Department of Chemical Engineering, Technion Israel Institute of Technology, Haifa 32000, Israel., Panigrahy D; Department of Microbiology and Immunology, Harvard Medical School, Boston 02115, USA., Kotelianski V; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA., Langer R; Harvard-MIT Division of Health Sciences and Technology, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA.; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA.; Institute for Medical Engineering and Science, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA.; Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA., Anderson DG; Harvard-MIT Division of Health Sciences and Technology, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA.; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA.; Institute for Medical Engineering and Science, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA.; Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA.

المصدر: Nature nanotechnology [Nat Nanotechnol] 2014 Aug; Vol. 9 (8), pp. 648-655. Date of Electronic Publication: 2014 May 11.

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.

بيانات الدورية: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101283273 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1748-3395 (Electronic) Linking ISSN: 17483387 NLM ISO Abbreviation: Nat Nanotechnol Subsets: MEDLINE

مواضيع طبية MeSH: RNA Interference*, Endothelial Cells/*metabolism , Nanoparticles/*chemistry , Polymers/*chemistry , RNA, Small Interfering/*administration & dosage, Animals ; Cell Line ; Humans ; Mice ; Nanoparticles/ultrastructure ; Neoplasms/genetics ; Neoplasms/therapy ; RNA, Small Interfering/genetics ; RNA, Small Interfering/therapeutic use

المؤلفون: Ruda VM; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts, United States of America., Chandwani R; Laboratory of Immune Cell Epigenetics and Signaling, Rockefeller University, New York, New York, United States of America., Sehgal A; Alnylam Pharmaceuticals, Cambridge, Massachusetts, United States of America., Bogorad RL; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts, United States of America., Akinc A; Alnylam Pharmaceuticals, Cambridge, Massachusetts, United States of America., Charisse K; Alnylam Pharmaceuticals, Cambridge, Massachusetts, United States of America., Tarakhovsky A; Laboratory of Immune Cell Epigenetics and Signaling, Rockefeller University, New York, New York, United States of America., Novobrantseva TI; Alnylam Pharmaceuticals, Cambridge, Massachusetts, United States of America., Koteliansky V; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts, United States of America.

المصدر: PloS one [PLoS One] 2014 Jul 03; Vol. 9 (7), pp. e101749. Date of Electronic Publication: 2014 Jul 03 (Print Publication: 2014).

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE

مواضيع طبية MeSH: Argonaute Proteins/*metabolism , Eukaryotic Initiation Factors/*metabolism , Fibroblasts/*cytology , Liver/*metabolism , RNA, Messenger/*genetics, Animals ; Argonaute Proteins/genetics ; Cells, Cultured ; Embryo, Mammalian/cytology ; Female ; Fibroblasts/metabolism ; Mice ; Mice, Inbred C57BL ; Mice, Transgenic ; NIH 3T3 Cells ; RNA Interference

المؤلفون: Bogorad RL; 1] David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA [2]., Yin H; 1] David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA [2]., Zeigerer A; Max Planck Institute of Molecular Cell Biology and Genetics, 01307 Dresden, Germany., Nonaka H; Max Planck Institute of Molecular Cell Biology and Genetics, 01307 Dresden, Germany., Ruda VM; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA., Zerial M; Max Planck Institute of Molecular Cell Biology and Genetics, 01307 Dresden, Germany., Anderson DG; 1] David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA [2] Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA [3] Harvard-MIT Division of Health Sciences and Technology, Cambridge, Massachusetts 02139, USA [4] Institute of Medical Engineering and Science, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA., Koteliansky V; 1] David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA [2] Skolkovo Institute of Science and Technology, ul. Novaya, d.100, Skolkovo 143025, Russian Federation.

المصدر: Nature communications [Nat Commun] 2014 May 21; Vol. 5, pp. 3869. Date of Electronic Publication: 2014 May 21.

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural

بيانات الدورية: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE

مواضيع طبية MeSH: Nanoparticles* , RNA, Small Interfering*, Carcinoma, Hepatocellular/*genetics , Hepatocytes/*metabolism , Integrin alpha Chains/*genetics , Integrin beta Chains/*genetics , Liver Neoplasms, Experimental/*genetics , Proto-Oncogene Proteins c-met/*metabolism, Animals ; Cell Proliferation ; Disease Progression ; Down-Regulation ; Gene Knockdown Techniques ; Mice

المؤلفون: Zeigerer A; Max Planck Institute of Molecular Cell Biology and Genetics, 01307 Dresden, Germany., Gilleron J, Bogorad RL, Marsico G, Nonaka H, Seifert S, Epstein-Barash H, Kuchimanchi S, Peng CG, Ruda VM, Del Conte-Zerial P, Hengstler JG, Kalaidzidis Y, Koteliansky V, Zerial M

المصدر: Nature [Nature] 2012 May 23; Vol. 485 (7399), pp. 465-70. Date of Electronic Publication: 2012 May 23.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 0410462 Publication Model: Electronic Cited Medium: Internet ISSN: 1476-4687 (Electronic) Linking ISSN: 00280836 NLM ISO Abbreviation: Nature Subsets: MEDLINE

مواضيع طبية MeSH: Endosomes/*metabolism , Lysosomes/*metabolism , rab5 GTP-Binding Proteins/*metabolism, Animals ; Cell Polarity ; Cells, Cultured ; Endocytosis ; Gene Knockdown Techniques ; Hepatocytes/cytology ; Hepatocytes/metabolism ; Isoenzymes/biosynthesis ; Isoenzymes/deficiency ; Isoenzymes/genetics ; Isoenzymes/metabolism ; Lipoproteins, LDL/metabolism ; Liver/cytology ; Liver/enzymology ; Liver/metabolism ; Mice ; Multivesicular Bodies/metabolism ; Organ Specificity ; Protein Biosynthesis ; RNA Interference ; RNA, Messenger/analysis ; RNA, Messenger/genetics ; Time Factors ; Vesicular Transport Proteins/metabolism ; rab5 GTP-Binding Proteins/biosynthesis ; rab5 GTP-Binding Proteins/deficiency ; rab5 GTP-Binding Proteins/genetics